<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1911246264
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        FENAM FORTE 500MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MEFENAMIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        9.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jazeera Pharmaceutical Industries (JPI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AG01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;Fenam forte Tablets belongs to a group of medicines called non-steroid anti-inflammatory drugs (NSAIDs). These medicines reduce pain and inflammation, and bring down a high temperature.</p><p>Fenam forte Tablets are most commonly used for relief of mild to moderate pain including muscle pains and pain after injury, headaches and toothaches, period pains and pain following an operation or after childbirth, pain due to rheumatoid arthritis and osteoarthrosis. It is also used to treat excessively heavy periods caused by abnormal function and presence of a contraceptive coil, where the disease in the pelvis has been ruled out.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Fenam forte</strong></p><ul><li>You know that you are allergic to Mefenamic Acid or any of the other ingredients in these Tablets (listed in section 6)</li><li>You currently have a stomach ulcer or bleeding</li><li>You have suffered from stomach ulcers or bleeding two or more times in the past</li><li>You suffer from inflammatory bowel disease</li><li>You show any signs of allergy (such as asthma, hay fever or skin rash) to aspirin, ibuprofen or other NSAIDs. An allergic reaction may include swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing.</li><li>You have severe problems with your kidneys or liver</li><li>You suffer from severe heart failure</li><li>You had a major heart surgery</li><li>You are in the last three months of pregnancy</li><li>You are breast feeding.</li></ul><p><strong>Take special care with Fenam forte </strong></p><p><strong>Tell your doctor:</strong></p><ul><li>You have had an ulcer or some other problem affecting your stomach, or intestines</li><li>You have asthma or wheezing attacks (or if you have had asthma in the past)</li><li>You have any heart, liver or kidney problems</li><li>You are elderly</li><li>You suffer from epilepsy (fits)</li><li>You suffer from any abnormality of the blood</li><li>You are dehydrated (for example you have been losing fluid through vomiting, diarrhoea or passing too much or too little, urine (fluids)</li><li>You have frequent headaches</li><li>You drink alcohol</li><li>You have a connective tissue disorder e.g. Systemic Lupus Erythematosus (SLE) resulting in joint pain, skin change and disorders of other organs</li><li>You have a problem with the metabolism of sugar in your body</li><li>You are trying to get pregnant (see section on pregnancy).</li></ul><p>If you are having a medical examination, tell the doctor that you are taking Fenam forte Tablets as they reduce the signs of fever and inflammation which would otherwise be noticed.</p><p>Medicines such as Fenam forte Tablets may be associated with a small increased risk of heart attack (&ldquo;myocardial infarction&rdquo;) or stroke.</p><p>Any risk is more likely with higher doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment.</p><p>If you have heart problems or suffered from a previous stroke or think that you may be at risk of these conditions (for example, if you have high blood pressure, diabetes or high cholesterol or are a smoker) you should discuss your treatment with your doctor or pharmacist.</p><p><strong>Using other medicines</strong></p><p>Tell your doctor or pharmacist if you are taking&nbsp; any other medicines, including any medicines that you buy without a prescription from your pharmacy, supermarket or health food shop.</p><p>Some<strong> Fenam forte Tablets may affect or be affected by the following medicines</strong></p><ul><li>Anticoagulants (drugs used to thin the blood to prevent blood clots, e.g. warfarin, heparin)</li><li>&nbsp;Antiplatelet tablets (to prevent blood clots, e.g. clopidogrel)</li><li>Antihypertensives (for the treatment of high blood pressure)</li><li>Diuretics (to make you pass more water)</li><li>Lithium (for depression)</li><li>Medicines for the treatment of heart conditions (e.g. digoxin)</li><li>Quinolone antibiotics (for an infection e.g. ciprofloxacin, norfloxacin and nalidixic acid)</li><li>Any other NSAID (for painful or inflammatory conditions e.g. aspirin, COX-2 selective inhibitors like valdecoxib, paracoxib and refocoxib, ibuprofen)</li><li>Mifepristone (used to terminate pregnancies)</li><li>Methotrexate (which can be used to treat certain tumours and other diseases including psoriasis and rheumatoid arthritis)</li><li>Ciclosporin or tacrolimus (used to suppress the body&rsquo;s immune system, e.g. following transplants or in diseases such as psoriasis and rheumatoid arthritis)</li><li>Corticosteroids (used for the treatment of asthma and various inflammatory conditions e.g. beclomethasone)</li><li>Probenecid used in treatment of swollen joints</li><li>Drugs used in diabetes (e.g. glibenclamide)</li><li>Drug used as antibiotics( e.g. Gentamycin, Neomycin, Kanamycin)</li><li>Zidovudine (an anti-viral drug)</li><li>SSRIs such as fluoxetine or sertaline (for depression).</li></ul><p><strong>Using with food and drink</strong></p><p>Fenam forte Tablets should be taken with or after food.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p>Fenam forte Tablets may make it difficult to become pregnant.</p><p>You should inform your doctor if you are planning to become pregnant or if you have problems becoming pregnant. Fenam forte Tablets should, if possible not be taken during pregnancy.</p><p>You should not take Fenam forte Tablets if you are in the last three months of pregnancy or if you are breast feeding, speak to your doctor or pharmacist before taking these Tablets. Fenam forte should not be given to the mother and the neonate, at the end of pregnancy, as there is a possibility of possible prolongation of bleeding time. During delivery, it may inhibit contractions of uterus resulting in delayed or prolonged delivery.</p><p><strong>Driving and using machines</strong></p><p>NSAIDs may sometimes cause symptoms such as drowsiness dizziness, weakness and visual disturbances. If you notice any such symptoms, do not drive or operate machinery and ask your doctor or pharmacist for advice.</p><p><strong>Important information about some of the ingredients of Fenam forte Tablets</strong></p><p>This medicine also contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use Fenam forte exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>Make sure you take your Tablets exactly as directed by your doctor.</p><p>The instructions will be written on the label. You should check with your doctor or pharmacist if you are not sure.</p><p>The tablets should be swallowed whole with water. Do not chew them or break them.</p><p><strong>Adults: </strong>The usual dose is one Tablets three times each day.</p><p>For excessively heavy periods, start taking your medicine on the first day of excessive bleeding and continue as directed by your doctor.</p><p>For period pains, start taking your medicine when you first notice the pain and continue as directed by your doctor.</p><p>As a general principle, the smallest effective dose should be used.</p><p><strong>Elderly: </strong>The adult dose can be used, although these Tablets should be used with caution in patients suffering from dehydration or kidney failure.</p><p><strong>Children: </strong>Mefenamic Acid Tablets are not recommended for use in children.</p><p>If you have a history of ulcers or some other problem affecting your stomach or intestines, you should inform your doctor or pharmacist if you notice any unusual symptoms affecting your abdomen(stomach) especially blood in your stomach, urine or stool, particularly if these symptoms occur during the initial phase of your treatment.</p><p><strong>If use more than you should</strong></p><p>If you (or someone else) take too many of these tablets, you may experience headache, nausea, vomiting, pain in abdomen, blood in stool or vomiting, diarrhoea, disorientation, excitation, coma, drowsiness, dizziness, ringing in ear, fainting, occasionally convulsions. In cases of significant poisoning acute kidney failure and liver damage are possible. Contact your doctor, or hospital immediately for advice. Bring the container with any remaining Tablets with you.</p><p><strong>If you forget to use Fenam forte</strong></p><p>If you miss a dose, leave it out and take the next dose whenever it is due. After that, just carry on as before. Do not take double the dose.</p><p>If you have any further questions about these Tablets, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Fenam forte can cause side effects, although not everybody gets them.</p><p>All medicines can cause allergic reactions although serious allergic reactions are rare. Any sudden wheeziness, difficulty in breathing, swelling of the eyelids, face or lips, rash or itching (especially affecting your whole body) should be reported to a doctor immediately.</p><p>Do not take if you have a peptic ulcer (ulcer in your stomach, or intestines) or bleeding in your stomach, or have had two or more episodes of peptic ulcer, stomach bleeding or perforation.</p><p><strong>STOP TAKING </strong>the medicine and tell your doctor if you experience:</p><ul><li>Indigestion or heart burn</li><li>Abdominal Pain (pains in your stomach) or other abdominal (stomach) symptoms.</li></ul><p>If you suffer from any of the following at anytime during your treatment <strong>STOP TAKING </strong>the medicine and see a doctor immediately.</p><ul><li>Pass blood in your stools/motions</li><li>Pass loose stool (Diarrhoea)</li><li>Pass black tarry stools</li><li>Vomit any blood or dark particles that look like coffee grounds.</li></ul><p><strong>Other Side Effects:</strong></p><ul><li>Mouth ulcers, malaise, fatigue, unexplained bruising, fever or sore throat may occasionally occur, if you notice any of these symptoms speak to your doctor as they may be signs of a blood disorder</li><li>If a skin rash or jaundice (yellowing of the skin or whites of eyes) occur, tell your doctor&nbsp;</li><li>Nausea (feeling sick), vomiting (being sick), loss of appetite</li><li>Fits</li><li>Rapid heart beats</li><li>Reactions to the sun</li><li>You may notice urinary symptoms such as blood in the urine or an increase or decrease in the amount of urine, ankle swelling, reduced salt levels in the body</li><li>Symptoms such as sleep disturbance, depression, confusion, nervousness, hallucinations (imagining sensations), noise in the ears or impaired hearing, vertigo, dizziness, tingling or other odd sensations, problems with your eyesight or drowsiness have occasionally been reported</li><li>Symptoms of aseptic meningitis such as, over-reaction of the skin to sunlight, persistent headache, a stiff neck, fever, drowsiness or muscle pain may occur in some patients (especially in patients with existing auto immune disorders, such as systemic lupus erythematosus, mixed connective tissue disease)</li><li>Medicines such as mefenamic acid may be associated with a small increased risk of heart attack (&quot;myocardial infarction&quot;) or stroke. Any risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment. If you have heart problems, previous stroke or think that you might be at risk of these conditions (for example if you have high blood pressure, diabetes or high cholesterol or are a smoker) you should discuss your treatment with your doctor or pharmacist.Your doctor may try to minimise any undesirable effect by giving you the lowest effective dose of Mefenamic Acid Tablets for the shortest amount of time necessary to control your symptoms.</li></ul><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Keep in original container to protect from light.</p><p>Store below 30&deg;C.</p><p>Do not use Fenam forte after the expiry date which is stated on the carton and the blister after EXP. The expiry date refers to the last day of that month.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Fenam forte capsule contain </strong></p><p><strong><em>Fenam forte 500 mg is</em></strong></p><p>The active substance is Mefenamic acid. contains 500 mg of Mefenamic acid.</p><p><strong>The other ingredients are</strong>: Pregelatinised starch phosphoric acid; Sodium Lauryl Sulfate ; Povidone K-30; Purified water; Microcrystalline cellulose; Acdisol; Lactose fast flo; Magnesium stearate; Talc; Titanium Dioxide; Polyethylene glycol; Hydroxy Propyl Methyl Cellulose; Simethicone Emulsion; Quinoline yellow lake; Methacrylic acid copolymer; Colloidal silicon dioxide; Sicopharm brown lake</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Fenam forte 500 mg Tablet is Light brown, capsule shape film coated tablets, embossed with "JI" on the left side and "115" on the right side.
Pack size: blister 20 Tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The Marketing Authorisation </strong>for Fenam forte 500 mg Tablets is held by</p><p>Jazeera Pharmaceutical Industries (JPI)</p><p>Riyadh, Saudi Arabia, 11666 Riyadh, P.O.Box 106229</p><p>Telephone No.: +966-11-207-8172</p><p>Fax: +966-11-207-8097</p><p>Email: <u>medical@jpi.com.sa</u></p><p>&nbsp;</p><p>Fenam forte 500 mg tablets are <strong>manufactured by</strong></p><p>Jazeera Pharmaceutical Industries (JPI)</p><p>Riyadh, Saudi Arabia</p><p>11666 Riyadh, P.O.Box 106229</p><p>Tel. : +966-11-207-8172</p><p>Email: <u>medical@jpi.com.sa</u></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 11/2013, version 1.1 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>ينتمي فينام فورت الى مجموعة دوائية تسمى الأدوية المضادة للالتهاب غير الستيرويدية. حيث تقلل هذه الادوية الألم والألتهاب وتخفض الحرارة.&nbsp;</p><p>تستخدم أقراص فينام فورت غالباً للراحة من الآلام الخفيفة الى المعتدلة بما في ذلك آلام العضلات وآلام ما بعد الجراحة، والصداع، وألم الأسنان، والآم الدورة الشهرية والآلام التي تلي العمليات الجراحية أو الولادة، والألم الناتج عن التهاب المفاصل الروماتويدي والفصال العظمي. يستخدم أيضاً لعلاج الدورة الشهرية الشديدة التي تسببها وظائف غير طبيعية ووجود اللولب لمنع الحمل، لوقاية الحوض من الأمراض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>موانع استعمال فينام فورت:&nbsp;</strong></p><p>لا تستخدم فينام فورت:</p><ul><li dir="rtl">إذا كنت تعاني من حساسية لحمض الميفيناميك أو لإحدى المواد المستخدمة في تركيبة هذه الأقراص (مدرجة في القسم 6).</li><li dir="rtl">إذا كنت تعاني حالياً من قرحة قي المعدة أو نزيف.&nbsp;</li><li dir="rtl">إذا عانيت من قرحة المعدة أو النزيف مرتين أو أكثر في الماضي.&nbsp;</li><li dir="rtl">إذا كنت تعاني من مرض التهاب الأمعاء.&nbsp;</li><li dir="rtl">إذا ظهرت أي علامات حساسية (مثل الربو أو حمى القش أو الطفح الجلدي) للأسبرين أو الأيبوبروفين او مضادات الالتهاب غير الستيرويدية الأخرى. ويمكن أن يشمل رد الفعل التحسسي تورم في الوجه أو الشفتين أو الفم أو اللسان أو الحلق مما قد يسبب صعوبة في البلع أو التنفس.&nbsp;</li><li dir="rtl">إذا كنت تعاني من اضطرابات حادة في الكليتين أو الكبد.&nbsp;</li><li dir="rtl">إذا كنت تعاني من قصور القلب الحاد.</li><li dir="rtl">إذا خضعت لجراحة رئيسية للقلب.</li><li dir="rtl">إذا كنت الآن في الأشهر الثلاثة الأخيرة من الحمل.</li><li dir="rtl">إذا كنت مرضعة.&nbsp;</li></ul><p><strong>الاحتياطات عند استخدام فينام فورت:</strong></p><p>يجب استشارة طبيبك قبل إستخدام فينام فورت. في الحلات التالية:</p><ul><li dir="rtl">إذا كنت تعاني من قرحة أو بعض المشاكل الأخرى التي تؤثر على معدتك، أو الأمعاء</li><li dir="rtl">إذا كنت تعاني من الربو أو نوبات صفير (أو إذا عانيت من الربو في الماضي).</li><li dir="rtl">إذا كنت تعاني أية مشاكل في القلب أو الكبد أو الكلى.</li><li dir="rtl">إذا كنت مسناً.</li><li dir="rtl">إذا كنت تعاني من مرض الصرع (نوبات).</li><li dir="rtl">إذا كنت تعاني من أي خلل في الدم.</li><li dir="rtl">إذا كان جسمك يفتقد للسوائل (بسبب التقيؤ، أو الإسهال أو التبول الكثير أو القليل).&nbsp;</li><li dir="rtl">إذا كنت تعاني من صداع متكرر.</li><li dir="rtl">إذا كنت تشرب الكحول.</li><li dir="rtl">إذا كنت تعاني من اضطراب النسيج الضام مثل الذئبة الحمامية الجهازية مما يؤدي إلى آلام المفاصل، وتغير الجلد واضطرابات في&nbsp;الأعضاء الأخرى.&nbsp;</li><li dir="rtl">إذا كنت تعاني من مشكلة في استقلاب السكر في الجسم</li><li dir="rtl">إذا كنت تحاولين الحمل (انظري القسم المتعلق بالحمل).</li></ul><p>إذا كنت ستخضع لفحص طبي، أخبر الطبيب أنك تأخذ فينام فورت إذ أنها تقلل من علامات الحمى والألتهابات التي يجب ملاحظتها.</p><p>قد يرافق الأدوية مثل فينام زيادة خطر الإصابة بالنوبات القلبية البسيطة (&quot;احتشاء عضلة القلب&quot;) أو السكتة الدماغية.</p><p>إن أي خطر يكون أكثر احتمالاً مع الجرعات الأعلى والعلاج لفترة طويلة. لا تتجاوز الجرعة الموصى أو مدة العلاج.</p><p>إذا كنت تعاني من مشاكل في القلب أو سكتة دماغية سابقة أو تعتقد أنك معرض لخطر حدوث هذه الأمراض (مثلاً إذا كنت تعاني من ارتفاع ضغط الدم، أو مرض السكري أو ارتفاع الكوليسترول في الدم أو إذا كنت مدخناً) يجب عليك مناقشة العلاج مع طبيبك أو الصيدلي.</p><p><strong>التداخلات الدوائية مع الأدوية الأخرى أو الأعشاب أو المكملات الغذائية</strong></p><p>يجب استشارة طبيبك أو الصيدلي قبل إستخدام فينام فورت إذا كنت تأخذ أو أخذت مؤخراً أية أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها بدون وصفة طبية.</p><p>قد تتأثر هذه الأدوية في فينام فورت أو قد يؤثر في حسن أداءها:</p><ul><li dir="rtl">مضادات التخثر (العقاقير المستخدمة لتمييع الدم لمنع تجلط الدم، مثل الوارفارين، والهيبارين).&nbsp;</li><li dir="rtl">الأقراص المضادة للتصفح (لمنع تجلط الدم، مثل كلوبيدوغريل).</li><li dir="rtl">خافضات الضغط (لعلاج ارتفاع ضغط الدم).</li><li dir="rtl">مدرات البول (لزيادة التبول).</li><li dir="rtl">الليثيوم (للاكتئاب).</li><li dir="rtl">أدوية علاج أمراض القلب (مثل الديجوكسين).</li><li dir="rtl">مضادات كينولون الحيوية (للالتهاب مثل سيبروفلوكساسين، نورفلوكساسين وحمض الناليديكسيك).&nbsp;</li><li dir="rtl">أي مضادات التهاب غير ستيرويدية أخرى (للآلام أو الالتهابات مثل الأسبرين، مثبطات سيكلو أوكسيجيناز&nbsp; -2 الانتقائية مثل فالديكوكسيب، أو باراكوكسيب، أو ريفوكوكسيب أو أيبوبروفين).</li><li dir="rtl">ميفبريستون (يستخدم لإنهاء الحمل).&nbsp;</li><li dir="rtl">الميثوتريكسات&nbsp; (والتي يمكن استخدامها لعلاج بعض الأورام والأمراض الأخرى بما في ذلك الصدفية والتهاب المفاصل الروماتويدي).</li><li dir="rtl">السيكلوسبورين أو تاكروليماس (تستخدم لكبت نظام المناعة في الجسم، مثلاً بعد الزراعة أو عند الإصابة بأمراض مثل الصدفية والتهاب المفاصل الروماتويدي).</li><li dir="rtl">الكورتيكوستيرويدات ( تستخدم لعلاج الربو و إصابات الالتهابات المختلفة مثل بيكلوميثاسون).</li><li dir="rtl">البروبينيسيد المستخدم لعلاج تورم المفاصل.&nbsp;</li><li dir="rtl">الأدوية المستخدمة لعلاج مرض السكري (مثل غليبينكلاميد).</li><li dir="rtl">الأدوية المستخدمة كمضادات حيوية (مثل جنتاميسين، نيومايسين، كاناميسين).</li><li dir="rtl">زيدوفيودين (عقار مضاد للفيروسات).&nbsp;</li><li dir="rtl">مثبطات إعادة امتصاص السيروتونين الانتقائية مثل فلوكسيتين أو سيرتالين (للاكتئاب).&nbsp;</li></ul><p><strong>تناول فينام فورت مع الطعام والشراب&nbsp;</strong></p><p>يجب تناول فينام فورت مع أو بعد الطعام.</p><p><strong>الحمل والرضاعة&nbsp;</strong></p><p>يرجى إستشارة طبيبك أو الصيدلي قبل تناول أي دواء.&nbsp;</p><p>قد يجعل فينام فورت الحمل صعباً.</p><p>يرجى إستشارة طبيبك إذا كنت تخططين للحمل أو تعانين من مشاكل في الحمل. يجب ألا يستخدم فينام فورت أثناء الحمل.</p><p>يجب ألا تتناولي أقراص فينام فورت إذا كنت في الأشهر الثلاثة الأخيرة من الحمل أو إذا كنت مرضعة، تحدثي إلى الطبيب او الصيدلي قبل أخذ هذه الأقراص. لا ينبغي أن يعطى فينام للأم والوليد في النهاية الحمل، حيث ان هناك احتمالية لإطالة وقت النزيف. أثناء الولادة، قد يمنع تقلصات الرحم مما يؤدي إلى تأخر الولادة أو إطالتها.&nbsp;</p><p><strong>تأثير فينام فورت على القيادة واستخدام الآلات</strong></p><p>قد تسبب مضادات الالتهاب غير الستيرويدية أعراض مثل النعاس والدوخة والضعف واضطرابات بصرية. إذا لاحظت أي من هذه الأعراض يفضل عدم قيادة السيارات أو استخدام الآلات واسأل طبيبك أو الصيدلي للنصيحة.&nbsp;</p><p><strong>معلومات هامة حول بعض مكونات فينام فورت&nbsp;</strong></p><p>يحتوي فينام فورت على اللاكتوز. ينبغي أخذ هذا بعين الأعتبار إذا أخبرك طبيبك أنك لا تحتمل بعض السكريات. استشر طبيبك قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يرجى استخدام فينام فورت تماماً كما وصفه الطبيب أو استشارة الطبيب أو الصيدلي إذا كنت غير متأكد.&nbsp;</p><p>تأكد من أن تأخذ الأقراص حسب توجيهات الطبيب تماماً.&nbsp;</p><p>سوف يتم كتابة التعليمات على الملصق. يجب عليك التحقق مع طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p>يجب ابتلاع الأقراص كاملة مع الماء. لا تمضغها أو تقسمها.</p><p><strong>البالغين:&nbsp;</strong>الجرعة المعتادة هي قرص واحد ثلاث مرات يومياً.</p><p>للدورة الشهرية الشديدة، ابدئي بتناول الدواء في أول يوم من النزيف الشديد وتابعي حسب تعليمات الطبيب.&nbsp;</p><p>لآلام الدورة الشهرية، ابدئي بتناول دوائك عندما تلاحظين وجود ألم وتابعي حسب توجيهات الطبيب.</p><p>كمبدأ عام، يجب تناول أقل جرعة فعالة ممكنة.</p><p><strong>كبار السن:</strong>&nbsp;يمكن استخدام جرعة البالغين، على الرغم من أن هذه الأقراص يجب أن تستخدم بحذر من قبل المرضى الذين يعانون من الجفاف أو الفشل الكلوي.&nbsp;</p><p><strong>الأطفال:&nbsp;</strong>لا ينصح باستخدام حمض الميفيناميك من قبل الأطفال.&nbsp;</p><p>إذا كان لديك تاريخ مع القرحة أو بعض المشاكل الأخرى التي تؤثر على المعدة أو الأمعاء، يجب إبلاغ الطبيب أو الصيدلي إذا لاحظت أية أعراض غير عادية تؤثر على بطنك (المعدة) وخاصة الدم في معدتك، أو البول أو البراز، لا سيما إذا كانت هذه الأعراض تحدث خلال المرحلة الأولى من العلاج.</p><p><strong>الجرعة الزائدة من فينام فورت&nbsp;</strong></p><p>إذا أخذت (أو شخص آخر) الكثير من هذه الأقراص، قد تشعر بالصداع، والغثيان، والتقي، وآلام في البطن، أو دم في البراز أو قيء، أو إسهال، أو تشوش، أو تهيج، أو غيبوبة، أو نعاس، أو دوخة، أو طنين في الأذن، أو إغماء، أو التشنجات في بعض الأحيان. في حالات التسمم الخطرة من الممكن حدوث فشل كلوي حاد وتلف في الكبد. اتصل بطبيبك أو المستشفى على الفور للحصول على المشورة. أحضر أية أقراص متبقية معك.</p><p><strong>نسيان تناول جرعة فينام فورت&nbsp;</strong></p><p>إذا نسيت جرعة، اتركها وخذ الجرعة التالية في وقتها. بعد ذلك، تابع تناول الجرعات تماماً كالسابق. لا تأخذ جرعة مضاعفة.</p><p>إذا كان لديك أي اسئلة أخرى حول هذه الأقراص، إسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، قد يعاني بعض المرضى من أعراض نتيجة تناول فينام فورت.</p><p>يمكن لجميع الأدوية أن تسبب الحساسية على الرغم من أن التفاعلات الحساسية الخطيرة نادرة. أي أعراض صفير مفاجئ، أو صعوبة في التنفس، تورم في الجفون أو الوجه أو الشفتين، أو طفح جلدي أو كحة (خاصة تلك التي تؤثر على الجسم بأكمله) ينبغي أن يتم إبلاغها للطبيب على الفور.</p><p>لا تأخذ الدواء إذا كن تعاني من قرحة هضمية (قرحة في المعدة، أو الأمعاء) أو نزيف في المعدة، أو عانيت من اثنتين أو أكثر من نوبات القرحة الهضمية، نزيف المعدة أو الثقب.</p><p>توقف عن تناول الدواء وأخبر الطبيب إذا عانيت من:</p><ul><li dir="rtl">عسر الهضم أو الحرقة.&nbsp;</li><li dir="rtl">ألم في البطن (آلام في المعدة) أو غيرها من الأعراض الباطنية (المعدة).</li></ul><p>إذا عانيت من أي من التالي في أي وقت خلال العلاج يجب عليك إيقاف تناول الدواء ومراجعة الطبيب فوراً.</p><ul><li dir="rtl">إفراز الدم في البراز</li><li dir="rtl">إخراج براز لين (الإسهال)</li><li dir="rtl">إخراج براز أسود غامق.&nbsp;</li><li dir="rtl">تقيؤ الدم أو جزيئات داكنة تبدو كالقهوة.</li></ul><p>أعراض جانبية أخرى:</p><ul><li dir="rtl">تقرحات الفم، والشعور بالضيق والتعب وكدمات غير معروفة السبب. قد تحدث حمى أو التهاب الحلق في بعض الأحيان. إذا لاحظت أي من هذه الأعراض تحدث إلى طبيبك حيث أنها قد تكون دلائل على وجود خلل في الدم.</li><li dir="rtl">إذا ظهر طفح جلدي أو يرقان (اصفرار الجلد أو بياض العينين) أخبر طبيبك.</li><li dir="rtl">غثيان (الشعور بالغثيان)، تقيؤ، وفقدان الشهية</li><li dir="rtl">نوبات&nbsp;</li><li dir="rtl">دقات القلب السريعة&nbsp;</li><li dir="rtl">ردود فعل للشمس&nbsp;</li><li dir="rtl">قد تلاحظ أعراض بولية مثل وجود الدم في البول&nbsp;أو زيادة أو نقصان في كمية البول، وتورم في الكاحل، وانخفاض مستويات الملح في الجسم.</li><li dir="rtl">تم الإبلاغ عن أعراض مثل اضطراب النوم، والاكتئاب، والتشوش، والعصبية، والهلوسة (تخيل الأحاسيس)، والضوضاء في الأذنين أو ضعف السمع، الدوار، وخز أو احاسيس غريبة أخرى، ومشاكل في البصر أو النعاس.&nbsp;</li><li dir="rtl">قد تحدث أعراض التهاب السحايا العقيم مثل الإفراط في تفاعلات الجلد لأشعة الشمس، صداع مستمر ، تصلب في الرقبة، حمى، خمول، أو ألم العضلات لدى بعض المرضى (وخاصة المرضى الذين يعانون من اضطرابات المناعة الذاتية، مثل الذئبة الحمامية الجهازية وأمراض النسيج الضام المختلط).&nbsp;</li><li dir="rtl">قد تترافق بعض الأدوية مثل حمض الميفيناميك مع زيادة خطر الإصابة بالنوبات القلبية البسيطة (&quot;احتشاء عضلة القلب&quot;) أو السكتة الدماغية. يكون أي خطر أكثر احتمالاً مع الجرعات العالية والعلاج لفترة طويلة. لا تتجاوز الجرعة الموصى بها أو مدة العلاج. إذا كنت تعاني من مشاكل في القلب، أو سكتة دماغية سابقة أو تعتقد أنك قد تكون معرض لخطر حدوث هذه الحالات (مثل ارتفاع ضغط الدم، أو مرض السكري أو ارتفاع الكوليسترول في الدم أو إذا كنت مدخناً) يجب علي مناقشة العلاج مع طبيبك أو الصيدلي.&nbsp;</li><li dir="rtl">قد يحاول طبيبك تقليل أي تأثير غير مرغوب فيه عن طريق إعطائك أقل جرعة فعالة من حمض الميفيناميك لأقصر مدة من الوقت اللازم للسيرة عاى أعراضك.&nbsp;</li></ul><p>راجع طبيبك أو الصيدلي إذا ساءت أية من هذه الآثار الجانبية أو لاحظت ظهور أية آثار جانبية غير مدرجة في هذه النشرة.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إحفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.</p><p dir="RTL">لا تحفظ الدواء&nbsp;عند درجة حرارة أعلى&nbsp;من 30&deg;س. احفظه في العلبة الأصلية بعيداً عن الضوء.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية.</p><p dir="RTL">يشير تاريخ الانتهاء إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت أي علامات تلف واضحة عليه.</p><p dir="RTL">لا تتخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي حمض الميفيناميك يحتوي 500 مغ من حمض الميفيناميك.&nbsp;</p><p>المواد الأخرى المستخدمة في التركيبة التصنيعية هي النشا المهلم مسبقاً،حمض الفسفوريك; سلفات لوريل الصوديوم; بوفيدون k-30; ماء مقطر ؛ سيلولوز بلوري مكروي؛ أرديسول؛ لاكتوز سريع الرحض؛ ستيرات المغنيسيوم؛ تلك؛ ثاني أكسيد التيتانيوم؛ بولي ايثيلين غلايكول؛ هيدروكسي بروبيل ميثيل السليلوز؛ مستحلب السيميثيكون؛ كينولين أصفر ؛ حمض ميثاكريليك بلمر مشترك؛ ثاني أكسيد السيليكون الغروي؛ سيكوفارم بني.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص فينام فورت 500 مغ ذات لون بني فاتح على شكل كبسولات مغطاة بطبقة رقيقة. منقوش على أحد جانبيها &quot;JI &quot; وعلى الجانب الآخر &quot;115 &quot;.&nbsp;</p><p>حجم العبوة: 20 قرص</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اسم وعنوان مالك رخصة التسويق والمصنع</strong></p><p dir="RTL">الجزيرة للصناعات الدوائية<br />الرياض 11666، المملكة العربية السعودية، صندوق بريد 106229</p><p dir="RTL">هاتف:966112078172+</p><p dir="RTL">فاكس:966112078097+</p><p dir="RTL">ايميل:<u>medical@jpi.com.sa</u></p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على هذه النشرة بتاريخ 2013/11 رقم النسخة: 1.1
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Fenam forte® 500 mg Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 500 mg mefenamic acid 
For a full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Light brown, capsule shape film coated tablets, embossed with "JI" on the left side and "115" on the right side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mefenamic acid is a non-steroidal anti-inflammatory agent with analgesic properties, and a demonstrable antipyretic effect. It has been shown to inhibit prostaglandin activity.</p><p><strong>Indications</strong></p><ul><li>As an anti-inflammatory analgesic for the symptomatic relief of rheumatoid arthritis (including Still&#39;s Disease), osteoarthritis, and pain including muscular, traumatic and dental pain, headaches of most aetiology, post-operative and post-partum pain.</li><li>Primary dysmenorrhoea.</li><li>Menorrhagia due to dysfunctional causes and presence of an IUD when other pelvic pathology has been ruled out.</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).</p><p>For oral administration.</p><ul><li>Adults</li></ul><p>1 tablet (500mg) three times daily.</p><p>In menorrhagia to be administered on the first day of excessive bleeding and continued according to the judgement of the physician.</p><p>In dysmenorrhoea to be administered at the onset of menstrual pain and continued according to the judgement of the physician.</p><ul><li>Elderly (over 65 Years)&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;As for adults.</li></ul><p>Whilst no pharmacokinetic or clinical studies specific to the elderly have been undertaken with Fenam, it has been used at normal dosage in trials which included many elderly patients.</p><p>The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy.</p><p>Fenam should be used with caution in elderly patients suffering from dehydration and renal disease. Non-oliguric renal failure and proctocolitis have been reported mainly in elderly patients who have not discontinued mefenamic Acid after the development of diarrhoea.</p><ul><li>Children</li></ul><p>Safety and effectiveness in pediatric patients below the age of 14 have not been established.</p><ul><li>Do not exceed the stated dose.</li></ul><p>Fenam Forte tablets should be taken preferably with or after food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to mefenamic acid or any of the other ingredients.
Inflammatory bowel disease.
History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy.
Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
Severe heart failure, hepatic failure and renal failure (see section 4.4).
Because the potential exists for cross-sensitivity to aspirin, ibuprofen, or other non- steroidal anti-inflammatory drugs, mefenamic acid must not be given to patients who have previously shown hypersensitivity reaction (e.g. asthma, bronchospasm, rhinitis, angioedema or urticaria) to these medicines.
During the last trimester of pregnancy (see section 4.6).
Treatment of pain after coronary artery bypass graft (CABG) surgery.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2 and GI and cardiovascular risks below).</p><p>Patients on prolonged therapy should be kept under regular surveillance with particular attention to liver dysfunction, rash, blood dyscrasias or development of diarrhoea.</p><p>Appearance of any of these symptoms should be regarded as an indication to stop therapy immediately (see section 4.8).</p><p>Use with concomitant NSAIDs including cyclooxygenase 2 specific inhibitors (see section 4.5).</p><p>Prolonged use of any type of painkiller for headaches can make them worse. If this situation is experienced or suspected, medical advice should be obtained and treatment should be discontinued. The diagnosis of &#39;Medication Overuse Headache&#39; should be suspected in patients who have frequent or daily headaches despite (or because of) the regular use of headache medications.</p><p>Precaution should be taken in patients suffering from dehydration and renal disease, particularly the elderly.</p><p>Elderly: The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (See section 4.2).</p><p>Respiratory disorders: Caution is required if administered to patients suffering from, or with a previous history of, bronchial asthma since NSAIDs have been reported to precipitate bronchospasm in such patients.</p><p>Cardiovascular, Renal and Hepatic impairment: The administration of an NSAID may cause a dose dependant reduction in prostaglandin formation and precipitate renal failure. Patients at greatest risk of this reaction are those with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics and the elderly. Renal function should be monitored in these patients (see also section 4.3).</p><p>Cardiovascular and cerebrovascular effects: Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>Clinical trial and epidemiological data suggest that use of some NSAIDs (particularly at high doses and in long term treatment) may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). There are insufficient data to exclude such a risk for mefenamic acid.</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with mefenamic acid after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking).</p><p>As NSAIDs can interfere with platelet function, they should be used in caution in patients with intracranial haemorrhage and bleeding diathesis.</p><p>Gastrointestinal bleeding, ulceration and perforation: GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at any time during treatment, with or without warning symptoms or a previous history of serious GI events. Smoking and alcohol use are added risk factors.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for patients at risk of GI bleeding such as the elderly, and also for patients requiring concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (see below and 4.5).</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.</p><p>Caution should be advised in patients receiving concomitant medications which could increase the risk of gastrotoxicity or bleeding such as corticosteroids, anticoagulants such as warfarin, selective serotonin reuptake inhibitors or anti-platelet agents such as aspirin (see section 4.5).</p><p>When GI bleeding or ulceration occurs in patients receiving mefenamic acid the treatment should be withdrawn.</p><p>SLE and mixed connective tissue disease: In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (See section 4.8).</p><p>Skin reactions: Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported in association with use of NSAIDs (see section 4.8). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring in the majority of cases within the first month of treatment. Mefenamic acid should be stopped at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity.</p><p>Female fertility: The use of mefenamic acid may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of mefenamic acid should be considered.</p><p>In dysmenorrhoea and menorrhagia lack of response should alert the physician to investigate other causes.</p><p>Epilepsy: Caution should be exercised when treating patients suffering from epilepsy.</p><p>Sunset yellow may cause allergic-type reactions.</p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>In patients who are known or suspected to be poor CYP2C9 metabolisers based on previous history/experience with other CYP2C9 substrates, mefenamic acid should be administered with caution as they may have abnormally high plasma levels due to reduced metabolic clearance (see section 5.2)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concurrent therapy with other plasma protein binding drugs may necessitate a modification in dosage.</p><p>Anti-coagulants: NSAIDs may enhance the effects of anti-coagulants, such as warfarin (see section 4.4). Concurrent administration of mefenamic acid with oral anti-coagulant drugs requires careful prothrombin time monitoring.</p><p>It is considered unsafe to take NSAIDs in combination with Warfarin or Heparin unless under direct medical supervision.</p><p>Lithium: a reduction in renal lithium clearance and elevation of plasma lithium levels. Patients should be observed carefully for signs of lithium toxicity.</p><p>The following interactions have been reported with NSAIDs but have not necessarily been associated with Fenam Tablets:</p><p>Other analgesics including cyclooxygenase-2 selective inhibitors: avoid concomitant use of two or more NSAIDs (including aspirin) as this may increase the risk of adverse effects (see section 4.4).</p><p>Antidepressants: selective serotonin reuptake inhibitors (SSRIs): increased risk of gastrointestinal bleeding (see section 4.4).</p><p>Antihypertensives and diuretics: a reduction in antihypertensive and diuretic effect has been observed. Diuretics can increase the nephrotoxicity of NSAIDs.</p><p>ACE inhibitors and angiotensin-II-receptor antagonists: a reduction in antihypertensive effect and an increased risk of renal impairment especially in elderly patients. Patients should be adequately hydrated and the renal function assessed in the beginning and during concomitant therapy.</p><p>Aminoglycosides: reduction in renal function in susceptible individuals, decreased elimination of aminoglycoside and increased plasma concentrations.</p><p>Anti-platelet agents: increased risk of gastrointestinal ulceration or bleeding (see section 4.4).</p><p>Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma cardiac glycoside levels.</p><p>Ciclosporin: the risk of nephrotoxicity of ciclosporin may be increased with NSAIDs.</p><p>Corticosteroids: increased the risk of gastrointestinal ulceration or bleeding (see section 4.4).</p><p>Oral hypoglycaemic agents: inhibition of metabolism of sulfonylurea drugs, prolonged half-life and increased risk of hypoglycaemia.</p><p>Methotrexate: elimination of the drug can be reduced, resulting in increased plasma levels.</p><p>Mifepristone: NSAIDs should not be taken for 8-12 days after mifepristone administration, NSAIDs can reduce the effects of mifepristone.</p><p>Probenecid: reduction in metabolism and elimination of NSAIDs and metabolites.</p><p>Quinolone antibiotics: animal data indicates that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.</p><p>Tacrolimus: possible increased risk of nephrotoxicity when NSAIDS are given with tacrolimus.</p><p>Zidovudine: increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in HIV(+) haemaophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy: Congenital abnormalities have been reported in association with NSAID administration in man; however, these are low in frequency and do not appear to follow any discernible pattern. In view of the known effects of NSAIDs on the foetal cardiovascular system (risk of closure of the ductus arteriosus), use in the last trimester of pregnancy is contraindicated. The onset of labour may be delayed and the duration increased with an increased bleeding tendency in both mother and child (See section 4.3 Contraindications). NSAIDs should not be used during the first two trimesters of pregnancy or labour unless the potential benefit to the patient outweighs the potential risk to the foetus.</p><p>Lactation: Trace amounts of mefenamic acid may be present in breast milk and transmitted to the nursing infant. Therefore, mefenamic acid should not be taken by nursing mothers.</p><p>See section 4.4 Special warnings and precautions for use regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected, patients should not drive or operate machinery.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most frequently reported side effects associated with mefenamic acid involve the gastrointestinal tract.</p><p>Diarrhoea occasionally occurs following the use of mefenamic acid. Although this may occur soon after starting treatment, it may also occur after several months of continuous use. The diarrhoea has been investigated in some patients who have continued this drug in spite of its continued presence. These patients were found to have associated proctocolitis. If diarrhoea does develop the drug should be withdrawn immediately and this patient should not receive mefenamic acid again.</p><p>Frequencies are not known for the following adverse reactions:</p><p><strong>Blood and the lymphatic system disorders</strong></p><p>Haemolytic anaemia*, anaemia, hypoplasia bone marrow, haematocrit decreased, thrombocytopenic purpura, temporary lowering of the white blood cell count (leukopenia) with a risk of infection, sepsis, and disseminated intravascular coagulation. Agranulocytosis,&nbsp; aplastic&nbsp; anaemia, eosinophilia,&nbsp; &nbsp;neutropenia,&nbsp; pancytopenia, thrombocytopenia.</p><p>*reversible when mefenamic acid is stopped.</p><p><strong>Immune system disorders</strong></p><p>Hypersensitivity reactions have been reported following treatment with NSAIDs. These may consist of (a) non-specific allergic reactions and anaphylaxis (b) respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm, or dyspnoea or (c) assorted skin disorders including rashes of various types, pruritus, urticaria, purpura, angioedema, and more rarely exfoliative or bullous dermatoses (including epidermal necrolysis and erythema multiforme).</p><p><strong>Metabolism and nutritional disorders</strong></p><p>Glucose intolerance in diabetic patients, hyponatraemia.</p><p><strong>Pyschiatric disorders</strong></p><p>Confusion, depression, hallucinations, nervousness.</p><p><strong>Nervous system disorders</strong></p><p>Optic neuritis, headaches, paraesthesia, dizziness, drowsiness, reports of aseptic meningitis (especially in patients with existing auto-immune disorders, such as systemic lupus erythematosus, mixed connective tissue disease), with symptoms such as stiff neck, headache, nausea, vomiting, fever or disorientation (see section 4.4).</p><p>Blurred vision, convulsions, insomnia.</p><p><strong>Eye disorders</strong></p><p>Eye irritation, reversible loss of colour vision, visual disturbances.</p><p><strong>Ear and labyrinth disorders</strong></p><p>Ear pain, tinnitus, vertigo.</p><p><strong>Cardiac / Vascular disorders</strong></p><p>Oedema, hypertension and cardiac failure have been reported in association with NSAID treatment.</p><p>Clinical trial and epidemiological data suggest that use of some NSAIDs (particularly at high doses and in long term treatment) may be associated with an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4).</p><p>Palpitations.</p><p>Hypotension.</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p><p>Asthma, dyspnoea.</p><p><strong>Gastrointestinal disorders</strong></p><p>The most commonly observed adverse events are gastrointestinal in nature. Peptic ulcers, perforation or GI bleeding, sometimes fatal, particularly in the elderly, may occur (see section 4.4). Nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of colitis and Crohn&#39;s disease have been reported following administration. Less frequently, gastritis has been observed.</p><p>Elderly or debilitated patients seem to tolerate gastrointestinal ulceration or bleeding less well than other individuals and most spontaneous reports of fatal GI events are in this population.</p><p>Anorexia, colitis, enterocolitis, gastric ulceration with or without haemorrhage, pancreatitis, steatorrhea.</p><p><strong>Hepato-bilary disorders</strong></p><p>Borderline elevations of one or more liver function tests, cholestatic jaundice. Mild hepatotoxicity, hepatitis, hepatorenal syndrome.</p><p><strong>Skin and subcutaneous tissue disorders</strong></p><p>Angioedema, laryngeal oedema, erythema multiforme, face oedema, bullous reactions including Lyell&#39;s syndrome (toxic epidermal necrolysis) and Stevens-Johnson syndrome, perspiration, rash, photosensitivity reaction, pruritus and urticaria.</p><p><strong>Renal and urinary disorders</strong></p><p>Allergic glomerulonephritis, acute interstitial nephritis, dysuria, haematuria, nephrotic syndrome, non-oliguric renal failure (particularly in dehydration), proteinuria, renal failure including renal papillary necrosis.</p><p><strong>General disorders</strong></p><p>Fatigue, malaise, multi-organ failure, pyrexia.</p><p><strong>Investigations</strong></p><p>A positive reaction in certain tests for bile in the urine of patients receiving Mefenamic acid has been demonstrated to be due to the presence of the drug and its metabolites and not to the presence of bile.</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Center (NPC)</p><p>Fax: + (966-11) 2057662</p><p>Call NPC at: + (966-11) 2038222, Exts: 2317-2356-2340.</p><p>SFDA Call Center: 19999</p><p>e-mail: <u>npc.drug@sfda.gov.sa</u></p><p>Website: <u>https://ade.sfda.gov.sa/</u></p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>It is important that the recommended dose is not exceeded and the regime adhered to since some reports have involved daily dosages under 3g.</p><ul><li>Symptoms</li></ul><p>Symptoms include headache, nausea, vomiting epigastric pain, gastrointestinal bleeding, rarely diarrhoea, disorientation, excitation, coma, drowsiness, tinnitus, fainting, occasionally convulsions [Mefenamic acid has a tendency to induce tonic-clonic (grand mal) convulsions in overdose]. In cases of significant poisoning acute renal failure and liver damage are possible.</p><ul><li>Therapeutic measure</li></ul><p>Patients should be treated symptomatically as required within one hour of ingestion of a potentially toxic amount activated charcoal should be considered. Alternatively, in adults gastric lavage should be considered within one hour of ingestion of a potentially life-threatening overdose. Good urine output should be ensured. Renal and liver function should be closely monitored. Patients should be observed for at least four hours after ingestion of potentially toxic amounts. Frequent or prolonged convulsions should be treated with intravenous diazepam. Other measures may be indicated by the patient&#39;s clinical condition. Haemodialysis is of little value since mefenamic acid and its metabolites are firmly bound to plasma proteins.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Animal models</li></ul><p>Mefenamic acid is non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its anti-inflammatory effect was first established in the UV erythema model of inflammation. Further studies included inhibition of granulation tissue growth into subcutaneous cotton pellets in rats and carrageenin induced rat paw oedema tests. Antipyretic activity was demonstrated in yeast-induced pyresis in rats. In this model its antipyretic activity was roughly equal to that of phenylbutazone and flufenamic acid, but less than that of indomethacin.</p><p>Analgesic activity was demonstrated in tests involving pain sensitivity of rats paws inflamed by brewer&rsquo;s yeast. Mefenamic acid was less potent than flufenamic acid in this model.</p><p>Prostaglandins are implicated in a number of disease processes including inflammation, modulation of the pain response, dysmenorrhoea, menorrhagia and pyrexia.</p><p>In common with most NSAIDs mefenamic acid inhibits the action of prostaglandin synthetase (cyclo oxygenase). This results in a reduction in the rate of prostaglandin synthesis and reduced prostaglandin levels.</p><p>The anti-inflammatory activity of NSAIDs in the rat paw oedema test has been correlated with their ability to inhibit prostaglandin synthetase. When mefenamic acid is ranked in both these tests it falls between indomethacin and phenylbutazone and it is probable that inhibition of prostaglandin synthesis contributes to the pharmacological activity and clinical efficacy of mefenamic acid.</p><p>There is also considerable evidence that the fenamates inhibit the action of prostaglandins after they have been formed. They therefore both inhibit the synthesis and response to prostaglandins. This double blockade may well be important in their mode of action.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><ul><li>Absorption and Distribution</li></ul><p>Mefenamic acid is absorbed from the gastro intestinal tract. Peak levels of 10 mg/l occur two hours after the administration of a 1g oral dose to adults.</p><ul><li>Metabolism</li></ul><p>Mefenamic acid is predominantly metabolised by cytochrome P450 enzyme CYP2C9 in the liver, first to a 3 hydroxymethyl derivative (metabolite I) and then a 3 carboxyl derivative (metabolite II). Both metabolites undergo secondary conjugation to form glucuronides.</p><p>Therefore in patients who are known or suspected to be poor CYP2C9 metabolisers based on previous history/experience with other CYP2C9 substrates, mefenamic acid should be administered with caution as they may have abnormally high plasma levels due to reduced metabolic clearance.</p><ul><li>Elimination</li></ul><p>Fifty two percent of a dose is recovered from the urine, 6% as mefenamic acid, 25% as metabolite I and 21% as metabolite II. Assay of stools over a 3 day period accounted for 10-20 % of the dose chiefly as unconjugated metabolite II.</p><p>The plasma levels of unconjugated mefenamic acid decline with a half life of approximately two hours.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data does not add anything of further significance to the prescriber.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-&nbsp;&nbsp;&nbsp; Pregelatinised starch phosphoric acid</p><p>-&nbsp;&nbsp;&nbsp; Sodium Lauryl Sulfate</p><p>-&nbsp;&nbsp;&nbsp; Povidone K-30</p><p>-&nbsp;&nbsp;&nbsp; Purified water</p><p>-&nbsp;&nbsp;&nbsp; Microcrystalline cellulose</p><p>-&nbsp;&nbsp;&nbsp; Acdisol</p><p>-&nbsp;&nbsp;&nbsp; Lactose fast flo</p><p>-&nbsp;&nbsp;&nbsp; Magnesium stearate</p><p>-&nbsp;&nbsp;&nbsp; Talc</p><p>-&nbsp;&nbsp;&nbsp; Titanium Dioxide</p><p>-&nbsp;&nbsp;&nbsp; Polyethylene glycol</p><p>-&nbsp;&nbsp;&nbsp; Hydroxy Propyl Methyl Cellulose</p><p>-&nbsp;&nbsp;&nbsp; Simethicone Emulsion</p><p>-&nbsp;&nbsp;&nbsp; Quinoline yellow lake</p><p>-&nbsp;&nbsp;&nbsp; Methacrylic acid copolymer</p><p>-&nbsp;&nbsp;&nbsp; Colloidal silicon dioxide</p><p>-&nbsp;&nbsp;&nbsp; Sicopharm brown lake</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C in a dry place.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PVC+PVDC Clear <em>I </em>Aluminum Foil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non Stated</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries (JPI) 
Riyadh, Saudi Arabia
11666 Riyadh, P.O.Box 106229

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                04 July 2013
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>